Riversedge Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Riversedge Advisors's BIIB Position: Q3 2026 in Review
Riversedge Advisors increased its Biogen (BIIB) stake by 1.1% in Q3 2026, buying an estimated $4.03K and bringing the position to 1,765 shares worth $399K. The position accounts for 0.05% of the portfolio, ranked #186.
Riversedge Advisors first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 1,056 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Riversedge Advisors held 1,765 shares of Biogen worth $399K as of Q3 2026.
- Riversedge Advisors bought 19 Biogen shares in Q3 2026, an estimated $4.03K.
- Biogen made up 0.05% of Riversedge Advisors's portfolio in Q3 2026, its #186 holding.
- Riversedge Advisors first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
- 1,056 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.